Clincosm LogoSign in Get a demo

Non Small Cell Lung Cancer

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

Recruiting
  • Solid Tumor
  • +4 more
  • AB248
  • Pembrolizumab
  • Lafayette, Indiana
  • +2 more
Jan 25, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Duarte, California
  • +44 more
Dec 22, 2022

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Taletrectinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Beverly Hills, California
  • +58 more
Dec 13, 2022

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Terminated
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Dec 7, 2022

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

Recruiting
  • Mesothelioma
  • +5 more
  • Denver, Colorado
  • +5 more
Aug 8, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,

Recruiting
  • Any Advanced Solid Tumors
  • +6 more
  • Tampa, Florida
  • +7 more
Jul 13, 2022

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

Recruiting
  • Oncology
  • +16 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +4 more
May 27, 2022

NSCLC, NSCLC, Non-Small Cell Lung Carcinoma Trial in United States (efineptakin alfa, Atezolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • Mobile, Alabama
  • +14 more
May 12, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Non Small Cell Lung Cancer Trial in United States (Aglatimagene besadenovec)

Recruiting
  • Non Small Cell Lung Cancer
  • Aglatimagene besadenovec
  • Farmington, Connecticut
  • +10 more
Mar 28, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Nivolumab, Cisplatin, Vinorelbine)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Nivolumab
  • +8 more
  • Glendale, Arizona
  • +135 more
Feb 28, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022